RYTM
RHYTHM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$110.68
+28.04%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.18x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.21x
Liquidity & coverage
- Current ratio
- 2.78x
- Quick ratio
- 2.57x
- Cash ratio
- 2.13x
- Interest coverage
- -10.27x
- EBITDA / interest
- -9.50x
- Working capital
- $268.5M
Cash & dividend
- FCF / debt
- -23.68x
- Cash flow / debt
- -23.27x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026